Educational intervention to improve the inhalation technique in patients with chronic obstructive pulmonary disease (COPD)

ISRCTN ISRCTN15106246
DOI https://doi.org/10.1186/ISRCTN15106246
Secondary identifying numbers PI-0492/09 and EC10-193
Submission date
23/03/2010
Registration date
28/04/2010
Last edited
19/05/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Francisca Leiva Fernández
Scientific

Unidad Docente Medicina Familiar y Comunitaria
Distrito Sanitario Málaga
Plaza Hospital Civil s/n Pabellón 6 2ª planta
Málaga
29009
Spain

Phone +34 951 29 03 10
Email francisca.leiva.sspa@juntadeandalucia.es

Study information

Study designMulticentre patients' preference trial or comprehensive cohort design
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEfficacy of two educational interventions about inhalation technique in patients with chronic obstructive pulmonary disease (COPD): a preference study
Study acronymTECEPOC
Study objectivesThe application of two educational interventions in patients with chronic obstructive pulmonary disease (COPD) with inhaled therapy is going to improve in at least 25% the patients who perform a correct inhalation technique.

Please note, as of 19/05/2011 a continuation of this trial has been implemented. The modifications to the trial can be found under the date of update in the relevant sections below. The anticipated end date has therefore been extended from 31/12/2011 to 30/06/2013.
Ethics approval(s)1. Ethical Committee of Distrito Sanitario Málaga approved on the 1st March 2007
2. Ethical Committee of Distrito Sanitario Axarquía approved on the 13th May 2008
Health condition(s) or problem(s) studiedChronic obstructive pulmonary disease (COPD)
InterventionCurrent interventions (as of 19/05/2011)
The study is divided into two groups and five arms. The two groups are:
1. The patients' preferences group (two arms)
2. The randomised group (three arms)

In the preferences group, the two arms correspond to the two educational interventions designed for this study. In the randomised group, the three arms are as follows:

Intervention A: Written information -
We will give written information about inhalation technique to the patient. We will design a leaflet about the correct inhalation technique, containing the main devices the patients use in our area.

Intervention B: Written information about inhalation technique and instructor training -
We will give written information about inhalation technique to the patient (leaflet described above) and we are going to train the patient about correct inhalation technique.

Control group:
Treatment as usual.

The appointments are approximately 20 - 30 minutes, depending on the arm of study. When the participant been located in an intervention arm the visit will be more detailed. The follow-up is the same for all arms and will be for 12 months.

Visit schedule:

Intervention Group A and B:
Visit of inclusion: all the study data will be recorded and the inhalator technique will be tested
Visit 1: It will take place 1 month after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured and encouraging work about inhalers techniques and motivational aspects related with this will be individually applied.
Visit 2: I will take place 3 months after the intervention. all the study data will be recorded and encouraging work about inhalers techniques and motivational aspects related with this will be individually applied.
Visit 3: It will take place 6 months after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured and encouraging work about inhalers techniques and motivational aspects related with this will be individually applied.
Visit 4: I will take place 12 months after the intervention. All the study data will be recorded and encouraging work about inhalers techniques and motivational aspects related with this will be individually applied.

Control Group:
Visit of inclusion: all the study data will be recorded and the inhalator technique will be tested.
Visit 1: It will take place 1 month after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured.
Visit 2: I will take place 3 months after the intervention. All the study data will be recorded.
Visit 3: It will take place 6 month after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured.
Visit 4: I will take place 12 months after the intervention. All the study data will be recorded.

Previous interventions:
The study is divided into two groups and five arms. The two groups are:
1. The patients' preferences group (two arms)
2. The randomised group (three arms)

In the preferences group, the two arms correspond to the two educational interventions designed for this study. In the randomised group, the three arms are as follows:

Intervention A: Written information -
We will give written information about inhalation technique to the patient. We will design a leaflet about the correct inhalation technique, containing the main devices the patients use in our area.

Intervention B: Written information about inhalation technique and instructor training -
We will give written information about inhalation technique to the patient (leaflet described above) and we are going to train the patient about correct inhalation technique.

Control group:
Treatment as usual.

The appointments are approximately 20 - 30 minutes, depending on the arm of study. When the participant been located in an intervention arm the visit will be more detailed. The follow-up is the same for all arms and will be for 3 months.

Visit schedule:

Intervention Group A and B:
Visit of inclusion: all the study data will be recorded and the inhalator technique will be tested
Visit 1: It will take place 1 month after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured and encouraging work about inhalers techniques and motivational aspects related with this will be individually applied.
Visit 2: I will take place 3 months after the intervention. all the study data will be recorded and encouraging work about inhalers techniques and motivational aspects related with this will be individually applied.

Control Group:
Visit of inclusion: all the study data will be recorded and the inhalator technique will be tested.
Visit 1: It will take place 1 month after the intervention. Primary and secondary outcomes (not spirometry and quality of life) will be measured.
Visit 2: I will take place 3 months after the intervention. All the study data will be recorded.

Secondary Sponsor Details:
Dirección General de Farmacia y Productos Sanitarios de Ministerio de Sanidad, Política Social e Igualdad. (Spain)
Paseo del Prado 18-20
Madrid
28014
Spain
+34 915961000
+34 915964480
oiac@mspsi.es
http://www.msps.es
Intervention typeOther
Primary outcome measurePerformance of correct inhalation technique. The correct inhalation technique will be measured by an investigator following SEPAR guidelines. Measured at all visits
Secondary outcome measuresCurrent secondary outcomes measures (as of 19/05/2011):

1. Pick flow, measured at all visits
2. Dyspnoea (Baseline Dyspnoea Index [IDB] and Modified Medical Research Council [MMRC] questionnaires), measured at all visits
3. Functional status (spirometry), measured at visit of inclusion, visit 2 and visit 4.
4. Quality of life, measured with the Spanish version of the St George's Respiratory Questionnaire and the specifically created SeguiEPOC Questionnaire, measured at visit of inclusion, visit 2 and visit 4.

Previous secondary outcome measures:

1. Pick flow, measured at all visits
2. Dyspnoea (Baseline Dyspnoea Index [IDB] and Modified Medical Research Council [MMRC] questionnaires), measured at all visits
3. Functional status (spirometry), measured at visit of inclusion and visit 2
4. Quality of life, measured with the Spanish version of the St George's Respiratory Questionnaire and the specifically created SeguiEPOC Questionnaire, measured at visit of inclusion and visit 2
Overall study start date15/03/2010
Completion date30/06/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants495
Key inclusion criteria1. Confirmed COPD diagnose by spirometry (Spanish Society of Pulmonology and Thoracic Surgery [SEPAR] guidelines)
2. Belonging to the selected Primary Care Centres in Malaga area
3. Use of inhalatory therapy
4. Accepted to participate in the study and gives informed consent
5. Aged greater than or equal to 18 years, either sex
Key exclusion criteria1. Diagnosis of other respiratory conditions which are not included in the COPD definition
2. Cognitive impairment problems
Date of first enrolment15/03/2010
Date of final enrolment30/06/2013

Locations

Countries of recruitment

  • Spain

Study participating centre

Unidad Docente Medicina Familiar y Comunitaria
Málaga
29009
Spain

Sponsor information

Council of Andalusian Health Services (Consejería de Salud, Junta de Andalucia) (Spain)
Government

Avd de la Innovación s/n. Edificio Arena 1
Sevilla
41020
Spain

Phone +34 955 00 63 00
Email fundacion.progreso.salud@juntadeandalucia.es
Website http://www.juntadeandalucia.es/index.html
ROR logo "ROR" https://ror.org/03q4c3e69

Funders

Funder type

Government

Council of Andalusian Health Services (Consejería de Salud, Junta de Andalucia) (Spain)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan